Poseida, Roche collaborate on allogeneic CAR-T Cell therapies
The collaboration will focus on advancing multiple existing and additional next-generation cell therapies against targets in multiple myeloma,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Aug 22
The collaboration will focus on advancing multiple existing and additional next-generation cell therapies against targets in multiple myeloma,…
03 Aug 22
Caris Life Sciences and Xencor will jointly research, develop and commercialise XmAb bispecific antibodies directed against novel targets…
02 Aug 22
The new strategic collaboration will leverage Sosei Heptares’ StaR technology and SBDD platform and AbbVie’s extensive neuroscience expertise,…
01 Aug 22
Under the new agreement with the US government, the biotechnology company will receive up to $1.74bn for 66…
29 Jul 22
The current agreement builds on an existing partnership between ViiV Healthcare and MPP, where the two have manufactured…
20 Jul 22
The expanded collaboration requires SK bioscience to manufacture a version of Novavax’s Covid-19 vaccine that targets the Omicron…
19 Jul 22
Enterome will receive a €40m upfront payment in cash and equity and is eligible to receive additional payments,…
15 Jul 22
Theravance will receive total consideration of more than $1.5bn, including around $1.1bn in an upfront payment, and up…
13 Jul 22
GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology…
12 Jul 22
Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the…